Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Sep;58(9):4997-5004.
doi: 10.1128/AAC.02824-14. Epub 2014 May 27.

A new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131

Affiliations
Review

A new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131

Ritu Banerjee et al. Antimicrob Agents Chemother. 2014 Sep.

Abstract

Escherichia coli sequence type 131 (ST131) is an extensively antimicrobial-resistant E. coli clonal group that has spread explosively throughout the world. Recent molecular epidemiologic and whole-genome phylogenetic studies have elucidated the fine clonal structure of ST131, which comprises multiple ST131 subclones with distinctive resistance profiles, including the (nested) H30, H30-R, and H30-Rx subclones. The most prevalent ST131 subclone, H30, arose from a single common fluoroquinolone (FQ)-susceptible ancestor containing allele 30 of fimH (type 1 fimbrial adhesin gene). An early H30 subclone member acquired FQ resistance and launched the rapid expansion of the resulting FQ-resistant subclone, H30-R. Subsequently, a member of H30-R acquired the CTX-M-15 extended-spectrum beta-lactamase and launched the rapid expansion of the CTX-M-15-containing subclone within H30-R, H30-Rx. Clonal expansion clearly is now the dominant mechanism for the rising prevalence of both FQ resistance and CTX-M-15 production in ST131 and in E. coli generally. Reasons for the successful dissemination and expansion of the key ST131 subclones remain undefined but may include increased transmissibility, greater ability to colonize and/or persist in the intestine or urinary tract, enhanced virulence, and more-extensive antimicrobial resistance compared to other E. coli. Here we discuss the epidemiology and molecular phylogeny of ST131 and its key subclones, possible mechanisms for their ecological success, implications of their widespread dissemination, and future research needs.

PubMed Disclaimer

Figures

FIG 1
FIG 1
Schematic dendrogram of ST131 phylogeny reconstructed using whole-genome single nucleotide polymorphism analysis. Arrows indicate emergence of fimH30 allele, FQ resistance, and CTX-M-15 ESBL. Colors indicate resistance traits significantly associated with (although not confined to) specific lineages. FQ, fluoroquinolone; TMP-SMZ, trimethoprim-sulfamethoxazole; R, resistance.

Similar articles

Cited by

References

    1. Coque TM, Baquero F, Canton R. 2008. Increasing prevalence of ESBL-producing enterobacteriaceae in Europe. Euro Surveill. 13:19044 http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19044 - PubMed
    1. Nicolas-Chanoine M-H, Blanco J, Leflon-Guibout V, Demarty R, Alonso MP, Canica MM, Park Y-J, Lavigne J-P, Pitout J, Johnson JR. 2008. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J. Antimicrob. Chemother. 61:273–281. 10.1093/jac/dkm464 - DOI - PubMed
    1. Peirano G, Pitout JDD. 2010. Molecular epidemiology of Escherichia coli producing CTX-M-beta lactamases: the worldwide emergence of clone ST131 O25:H4. Int. J. Antimicrob. Agents 35:316–321. 10.1016/j.ijantimicag.2009.11.003 - DOI - PubMed
    1. Johnson JR, Johnston B, Clabots C, Kuskowski MA, Castanheira M. 2010. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin. Infect. Dis. 51:286–294. 10.1086/653932 - DOI - PubMed
    1. Rogers BA, Sidjabat HE, Paterson DL. 2011. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J. Antimicrob. Chemother. 66:1–14. 10.1093/jac/dkq415 - DOI - PubMed

Publication types